Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Broadcom
AVGO
|
+$67.3M |
| 2 |
Veralto
VLTO
|
+$60.2M |
| 3 |
Newmont
NEM
|
+$43.4M |
| 4 |
Vertiv
VRT
|
+$19.4M |
| 5 |
Webster Financial
WBS
|
+$17.3M |
Top Sells
| 1 |
Apple
AAPL
|
+$328M |
| 2 |
Microsoft
MSFT
|
+$244M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$237M |
| 4 |
VMW
VMware, Inc
VMW
|
+$130M |
| 5 |
NVIDIA
NVDA
|
+$109M |
Sector Composition
| 1 | Technology | 30.91% |
| 2 | Healthcare | 12.91% |
| 3 | Consumer Discretionary | 12.16% |
| 4 | Industrials | 9.36% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Global Net Lease
GNL
$1.81B
| $3.84M | ﹤0.01% |
385,557
-40,500
| -10% | -$403K |
|
1452
HNI Corp
HNI
$2.07B
| $3.84M | ﹤0.01% |
91,700
-10,300
| -10% | -$431K |
|
|
JWN
1453
DELISTED
Nordstrom
JWN
| $3.82M | ﹤0.01% |
207,100
-23,700
| -10% | -$437K |
|
1454
Agilysys
AGYS
$2.97B
| $3.82M | ﹤0.01% |
45,000
-5,200
| -10% | -$441K |
|
1455
ODP
ODP
$624M
| $3.8M | ﹤0.01% |
67,489
-8,900
| -12% | -$501K |
|
1456
Pebblebrook Hotel Trust
PEB
$1.38B
| $3.8M | ﹤0.01% |
237,512
-33,200
| -12% | -$531K |
|
1457
Tandem Diabetes Care
TNDM
$829M
| $3.79M | ﹤0.01% |
128,200
-13,800
| -10% | -$408K |
|
|
STR
1458
DELISTED
Sitio Royalties
STR
| $3.78M | ﹤0.01% |
160,907
-7,500
| -4% | -$176K |
|
1459
Hudbay
HBM
$5.35B
| $3.78M | ﹤0.01% |
686,000
-33,400
| -5% | -$184K |
|
1460
Brinker International
EAT
$6.84B
| $3.76M | ﹤0.01% |
87,000
-10,300
| -11% | -$445K |
|
1461
Construction Partners
ROAD
$7.02B
| $3.75M | ﹤0.01% |
86,200
-4,900
| -5% | -$213K |
|
1462
Liberty Live Group Series C
LLYVK
$9.23B
| $3.75M | ﹤0.01% |
100,245
-4,801
| -5% | -$180K |
|
1463
Dana Inc
DAN
$2.76B
| $3.74M | ﹤0.01% |
256,100
-29,400
| -10% | -$430K |
|
1464
MasterBrand
MBC
$1.71B
| $3.74M | ﹤0.01% |
251,700
-30,800
| -11% | -$457K |
|
|
IBTX
1465
DELISTED
Independent Bank Group, Inc.
IBTX
| $3.73M | ﹤0.01% |
73,222
-8,500
| -10% | -$432K |
|
1466
Renasant Corp
RNST
$3.68B
| $3.73M | ﹤0.01% |
110,600
-12,700
| -10% | -$428K |
|
1467
Nuvalent
NUVL
$5.8B
| $3.72M | ﹤0.01% |
50,500
+5,300
| +12% | +$390K |
|
1468
Coursera
COUR
$1.8B
| $3.72M | ﹤0.01% |
191,800
-23,600
| -11% | -$457K |
|
1469
IonQ
IONQ
$16.6B
| $3.71M | ﹤0.01% |
299,400
-32,000
| -10% | -$396K |
|
1470
Crinetics Pharmaceuticals
CRNX
$3.2B
| $3.71M | ﹤0.01% |
104,200
-12,200
| -10% | -$434K |
|
1471
AvidXchange
AVDX
$2.06B
| $3.7M | ﹤0.01% |
298,800
-33,000
| -10% | -$409K |
|
1472
Procept Biorobotics
PRCT
$2.07B
| $3.69M | ﹤0.01% |
88,100
+3,900
| +5% | +$163K |
|
1473
Standex International
SXI
$2.47B
| $3.69M | ﹤0.01% |
23,300
-2,900
| -11% | -$459K |
|
1474
Arvinas
ARVN
$568M
| $3.68M | ﹤0.01% |
89,500
-10,200
| -10% | -$420K |
|
1475
Worthington Enterprises
WOR
$3.17B
| $3.68M | ﹤0.01% |
64,000
-51,486
| -45% | -$2.96M |
|